Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 41

1.

Pathogenesis, treatment, and prevention of pneumococcal pneumonia.

van der Poll T, Opal SM.

Lancet. 2009 Oct 31;374(9700):1543-56. doi: 10.1016/S0140-6736(09)61114-4. Review.

PMID:
19880020
2.

Drug treatment of pneumococcal pneumonia in the elderly.

Neralla S, Meyer KC.

Drugs Aging. 2004;21(13):851-64. Review.

PMID:
15493950
3.

Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines.

Lynch JP 3rd, Zhanel GG.

Curr Opin Pulm Med. 2010 May;16(3):217-25. doi: 10.1097/MCP.0b013e3283385653. Review.

PMID:
20375783
4.

Streptococcus pneumoniae: does antimicrobial resistance matter?

Lynch JP 3rd, Zhanel GG.

Semin Respir Crit Care Med. 2009 Apr;30(2):210-38. doi: 10.1055/s-0029-1202939. Epub 2009 Mar 18. Review.

PMID:
19296420
5.

Streptococcus pneumoniae colonisation: the key to pneumococcal disease.

Bogaert D, De Groot R, Hermans PW.

Lancet Infect Dis. 2004 Mar;4(3):144-54. Review.

PMID:
14998500
6.

Immunosenescence and pneumococcal disease: an imbalance in host-pathogen interactions.

Krone CL, van de Groep K, Trzciński K, Sanders EA, Bogaert D.

Lancet Respir Med. 2014 Feb;2(2):141-53. doi: 10.1016/S2213-2600(13)70165-6. Epub 2013 Sep 18. Review.

PMID:
24503269
7.

Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.

O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T; Hib and Pneumococcal Global Burden of Disease Study Team.

Lancet. 2009 Sep 12;374(9693):893-902. doi: 10.1016/S0140-6736(09)61204-6. Review.

PMID:
19748398
8.

Current concepts in host-microbe interaction leading to pneumococcal pneumonia.

Vernatter J, Pirofski LA.

Curr Opin Infect Dis. 2013 Jun;26(3):277-83. doi: 10.1097/QCO.0b013e3283608419. Review.

9.
10.

[An update of Streptococcus pneumoniae: from genomic to clinic].

Wintenberger C.

Med Mal Infect. 2010 Oct;40(10):605-9. doi: 10.1016/j.medmal.2010.07.014. Epub 2010 Oct 8. Review. French. No abstract available.

PMID:
20934286
11.

[Treatment and prevention of pneumococcal pneumonia].

Léophonte P, Mazières J.

Rev Prat. 2003 Sep 15;53(13):1451-7. Review. French.

PMID:
14558267
12.
13.

Penicillin resistance and serotyping of Streptococcus pneumoniae in Latin America.

Camargos P, Fischer GB, Mocelin H, Dias C, Ruvinsky R.

Paediatr Respir Rev. 2006 Sep;7(3):209-14. Epub 2006 Aug 8. Review.

PMID:
16938644
14.

The transforming Streptococcus pneumoniae in the 21st century.

Hsieh YC, Lee WS, Shao PL, Chang LY, Huang LM.

Chang Gung Med J. 2008 Mar-Apr;31(2):117-24. Review.

15.

Molecular pathogenesis of pneumococcal pneumonia.

McCullers JA, Tuomanen EI.

Front Biosci. 2001 Aug 1;6:D877-89. Review.

PMID:
11502489
16.

Pneumococcal pneumonia: mechanisms of infection and resolution.

Dockrell DH, Whyte MKB, Mitchell TJ.

Chest. 2012 Aug;142(2):482-491. doi: 10.1378/chest.12-0210. Review.

17.

Pneumococcal conjugate vaccines. A review.

Galiza EP, Heath PT.

Minerva Med. 2007 Apr;98(2):131-43. Review.

PMID:
17519855
18.

Pneumolysin as a vaccine and drug target in the prevention and treatment of invasive pneumococcal disease.

Cockeran R, Anderson R, Feldman C.

Arch Immunol Ther Exp (Warsz). 2005 May-Jun;53(3):189-98. Review.

PMID:
15995579
19.
20.

The fundamental link between pneumococcal carriage and disease.

Simell B, Auranen K, Käyhty H, Goldblatt D, Dagan R, O'Brien KL; Pneumococcal Carriage Group.

Expert Rev Vaccines. 2012 Jul;11(7):841-55. Review.

PMID:
22913260

Supplemental Content

Support Center